Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria

…, T Coetzee, G Comi, J Correale, F Fazekas… - The Lancet …, 2018 - thelancet.com
The 2010 McDonald criteria for the diagnosis of multiple sclerosis are widely used in research
and clinical practice. Scientific advances in the past 7 years suggest that they might no …

Neurofilaments as biomarkers in neurological disorders

…, C Barro, L Kappos, M Comabella, F Fazekas… - Nature Reviews …, 2018 - nature.com
Neuroaxonal damage is the pathological substrate of permanent disability in various
neurological disorders. Reliable quantification and longitudinal follow-up of such damage are …

2021 MAGNIMS–CMSC–NAIMS consensus recommendations on the use of MRI in patients with multiple sclerosis

…, N de Stefano, C Enzinger, F Fazekas… - The Lancet …, 2021 - thelancet.com
The 2015 Magnetic Resonance Imaging in Multiple Sclerosis and 2016 Consortium of Multiple
Sclerosis Centres guidelines on the use of MRI in diagnosis and monitoring of multiple …

Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration

…, GJ Biessels, C Cordonnier, F Fazekas… - The Lancet …, 2013 - thelancet.com
Cerebral small vessel disease (SVD) is a common accompaniment of ageing. Features
seen on neuroimaging include recent small subcortical infarcts, lacunes, white matter …

A new rating scale for age-related white matter changes applicable to MRI and CT

LO Wahlund, F Barkhof, F Fazekas, L Bronge… - Stroke, 2001 - Am Heart Assoc
Background and Purpose—MRI is more sensitive than CT for detection of age-related white
matter changes (ARWMC). Most rating scales estimate the degree and distribution of …

MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging

F Fazekas, JB Chawluk, A Alavi… - American journal of …, 1987 - Am Roentgen Ray Soc
The type, frequency, and extent of MR signal abnormalities in Alzheimer's disease and normal
aging are a subject of controversy. With a 1.5-MR unit we studied 12 Alzheimer patients, …

Pathologic correlates of incidental MRI white matter signal hyperintensities

F Fazekas, R Kleinert, H Offenbacher, R Schmidt… - Neurology, 1993 - AAN Enterprises
Fazekas F. Magnetic resonance signal abnormalities in asymptomatic individuals: their …
Pollay M, Curl F. Secrction of ccrebrospinal fluid by ventricular ependyma of the rabbit. Am J …

[HTML][HTML] MRI-guided thrombolysis for stroke with unknown time of onset

…, B Cheripelli, TH Cho, F Fazekas… - … England Journal of …, 2018 - Mass Medical Soc
Background Under current guidelines, intravenous thrombolysis is used to treat acute stroke
only if it can be ascertained that the time since the onset of symptoms was less than 4.5 …

Effect of glatiramer acetate on conversion to clinically definite multiple sclerosis in patients with clinically isolated syndrome (PreCISe study): a randomised, double …

…, L Moiola, O Bajenaru, A Carra, I Elovaara, F Fazekas… - The Lancet, 2009 - thelancet.com
Background Glatiramer acetate, approved for the treatment of relapsing-remitting multiple
sclerosis, reduces relapses and disease activity and burden monitored by MRI. We assessed …

Histopathologic analysis of foci of signal loss on gradient-echo T2*-weighted MR images in patients with spontaneous intracerebral hemorrhage: evidence of …

F Fazekas, R Kleinert, G Roob… - American journal …, 1999 - Am Soc Neuroradiology
BACKGROUND AND PURPOSE: Patients with spontaneous intracerebral hemorrhage (ICH)
frequently have small areas of signal loss on gradient-echo T2*-weighted MR images, …